Sustained release of injectable zinc-recombinant hirudin suspensions: development and validation of in vitro release model
- 1 May 1998
- journal article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 45 (3) , 259-264
- https://doi.org/10.1016/s0939-6411(98)00008-3
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Immunoassays in Monitoring Biotechnological DrugsTherapeutic Drug Monitoring, 1996
- Controlled release of transforming growth factor-β from lipid-based microcylindersJournal of Microencapsulation, 1995
- Selective thrombin inhibitors: The next generation of anticoagulantsJournal of the American College of Cardiology, 1993
- Preparation of monoclonal antibodies to hirudin and hirudin peptidesEuropean Journal of Biochemistry, 1990
- Physiologische ChemiePublished by Springer Nature ,1988
- Kinetics of the inhibition of thrombin by hirudinBiochemistry, 1986
- An in-vitro test for the duration of action of insulin suspensionsJournal of Pharmacy and Pharmacology, 1984
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976